NUsurface

NUsurface is the brand and operating identity used for the investigational NUsurface Meniscus Implant program, a knee meniscus replacement device focused on patients with persistent pain after medial meniscus surgery. The website presents NUsurface as an orthopedic implant business centered on joint preservation and restoration of meniscal function, but the underlying sponsoring company is Active Implants, a private medical device company based in Memphis, Tennessee. Its lead and apparently sole product is a polymeric artificial meniscus intended to redistribute knee load and improve pain and function without fixation to bone or soft tissue. The product has been studied in multiple clinical programs including VENUS, SUN, and MERCURY, and was under FDA De Novo review as of the 2023 FDA advisory committee materials. NUsurface is best understood as a branded orthopedic device program rather than a diversified biotech or pharma company.